The present article encompasses resolution and X-ray crystallographically confirmed absolute stereochemistry-correlated anticancer activity of diastereomeric 3-(tert-butoxycarbonyl)-2-(2-aryl)thiazolidine-4-carboxylic acids against MCF7 breast cancer cells.